PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.66%
Negative revenue growth while ADI stands at 0.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.81%
Negative gross profit growth while ADI is at 2.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
-18.38%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.60%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.76%
Negative net income growth while ADI stands at 14.36%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.86%
Negative EPS growth while ADI is at 14.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.86%
Negative diluted EPS growth while ADI is at 12.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.91%
Share reduction while ADI is at 1.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.81%
Reduced diluted shares while ADI is at 0.86%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
6.82%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
4.17%
OCF growth under 50% of ADI's 28.24%. Michael Burry might suspect questionable revenue recognition or rising costs.
6.33%
FCF growth under 50% of ADI's 22.98%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
160.86%
10Y revenue/share CAGR above 1.5x ADI's 44.91%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
43.38%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-7.30%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
168.15%
10Y OCF/share CAGR at 75-90% of ADI's 221.00%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
26.50%
Below 50% of ADI's 84.95%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
5.20%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
137.70%
Net income/share CAGR at 75-90% of ADI's 172.79%. Bill Ackman would press for strategic moves to boost long-term earnings.
463.32%
5Y net income/share CAGR above 1.5x ADI's 30.63%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-41.46%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
117.37%
10Y equity/share CAGR above 1.5x ADI's 71.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.69%
Below 50% of ADI's 82.60%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
11.74%
Below 50% of ADI's 41.93%. Michael Burry suspects a serious short-term disadvantage in building book value.
2060.94%
Dividend/share CAGR of 2060.94% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
172.72%
5Y dividend/share CAGR above 1.5x ADI's 70.00%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
129.94%
3Y dividend/share CAGR above 1.5x ADI's 54.76%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-21.06%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
0.29%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.59%
Negative asset growth while ADI invests at 3.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.31%
We have a declining book value while ADI shows 1.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.06%
We’re deleveraging while ADI stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-5.98%
Our R&D shrinks while ADI invests at 1.62%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.86%
We cut SG&A while ADI invests at 0.43%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.